EUDA Health Holdings
EUDA
5 hedge funds and large institutions have $253K invested in EUDA Health Holdings in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.06% less ownership
Funds ownership: 0.11% → 0.05% (-0.06%)
81% less capital invested
Capital invested by funds: $1.3M → $253K (-$1.05M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$39.6K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.2K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$48 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.15M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11.1K |
EUDA Hedge Fund Activity: Q3 2025 in Review
5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings (EUDA) for Q3 2025, worth a combined $253K — down 81% from $1.3M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new EUDA positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $39.6K. The largest seller was Hudson Bay Capital Management, cutting an estimated $1.15M.
- 5 institutional investors held EUDA Health Holdings (EUDA) as of Q3 2025, up from 4 in Q2 2025.
- Funds reported $253K of EUDA Health Holdings stock for Q3 2025, down 81% quarter-over-quarter.
- 1 fund opened new EUDA Health Holdings positions in Q3 2025 and 0 closed out, a net change of +1 holder.
- The largest EUDA Health Holdings buyer in Q3 2025 was Citadel Advisors, an estimated $39.6K added.
- The largest EUDA Health Holdings seller in Q3 2025 was Hudson Bay Capital Management, an estimated $1.15M sold.
Based on aggregated 13F filings for Q3 2025.